IDO1 expression is increased in many human tissues, and it is overexpressed in the majority of cancers (90% of glioma cells) by proinflammatory cytokines, such as IFN-γ and TNF-α, or in response to interaction with tumor-infiltrating T or NK cells [714,715]. This evidence concerns the gene IDO1 and glioma.